Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Second milestone in Actelion and Merck's renin alliance

March 24, 2005

Agents for cardiovascular diseases described in patent literature

March 21, 2005

Iloprost increases the efficacy of bosentan therapy in PAH patients

March 17, 2005

Novel ACE2 inhibitor identified using structure-based method

March 16, 2005

Zealand Pharma and Wyeth expand gap junction modulator collaboration

March 16, 2005

GSK reports the discovery of new ROCK/Aurora kinase inhibitors

March 11, 2005

deCODE opens phase I study for DG-041 for atherosclerosis

March 11, 2005

Cytokinetics selects cardiac myosin activator for development candidate

March 11, 2005

Remodulin receives the first European approval in France

March 10, 2005

SPA agreement for pivotal study of INO-1001

March 10, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...